Acadia Healthcare Stock Down 60% as One Investor Slashes Stake to Less Than 1% of Assets Acadia Healthcare runs a broad network of behavioral health facilities, serving patients across the U.S. and Puerto Rico.
KBR Stock Down 20% as Investor Slashes $41 Million Stake Despite $23 Billion Backlog KBR delivers engineering and technology solutions for government and industrial clients across defense, energy, and infrastructure.
What to Know About UniFirst Stock as One Fund Boosts Bet to $89 Million UniFirst provides uniforms and facility services to varied industries, leveraging recurring contracts across North America and Europe.
Why One Hedge Fund Just Put $246 Million Into This Life Sciences Supplier One fund has turned nearly a third of its portfolio into a bet that this beaten-down science supplier is due for a rebound.
Why One Fund Dumped Its Entire $15 Million Stake as This Defense Stock Posted $47 Billion in Backlog Why would a fund step away from a stock that’s quietly building one of the strongest backlogs in federal contracting?
Why One Fund Just Bet $64 Million on a Healthcare Stock Down 63% This Past Year This hedge fund just made a bold bet on a behavioral-health giant in the middle of a reset—here’s what they may be seeing.
Orthofix Medical Inc (NASDAQ:OFIX) Surpasses Q3 2025 Profit Expectations Despite Muted Market Reaction Orthofix (OFIX) Q3 2025 earnings beat estimates with $0.20 EPS vs. $(0.41) forecast. Revenue of $205.6M also surpassed expectations, driven by strong spine and orthopedics growth.
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.
This Analyst Says Orthopedic-Focused Orthofix Medical Is Positioned For Growth Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.
OFIX Stock Earnings: Orthofix Medical Beats EPS, Beats Revenue for Q2 2024 OFIX stock results show that Orthofix Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
OFIX Stock Earnings: Orthofix Medical Meets EPS, Beats Revenue for Q1 2024 OFIX stock results show that Orthofix Medical met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
OFIX Stock Earnings: Orthofix Medical Misses EPS, Beats Revenue for Q4 2023 OFIX stock results show that Orthofix Medical missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Earnings Scheduled For March 5, 2024 Companies Reporting Before The Bell • NIO (
NYSE:NIO ) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
